Non-Invasive Monitoring Systems Reached a Collaborate Agreement with Naval Medical Research Center
21 9월 2010 - 12:01AM
Business Wire
Non-Invasive Monitoring Systems, Inc. [NIMS](OTCBB:NIMU)
announced that it has entered into a Cooperative Research and
Development Agreement (CRADA) with the Naval Medical Research
Center (NMRC) in Silver Springs, MD to evaluate the benefit of
Exer-Rest for patients with traumatic brain injury (TBI).
The Exer-Rest® is a Class I Exempt, non-invasive medical device
which applies Whole Body Periodic Acceleration (WBPA) from
head-to-foot to improve circulation and provide pain relief.
Military service members are being deployed to areas where they
are at risk for blast exposures from improvised explosive devices
(IEDs), suicide bombs, land mines, mortar rounds, rocket-propelled
grenades etc. According to the United States Army, $361 million was
spent on care and research for TBI in 2008 and 2009.
Dr. Marvin Sackner, NIMS founder and CEO noted “Whole Body
Periodic Acceleration therapy increases endogenous nitric oxide in
the circulation, a natural anti-inflammatory molecule that offers
potential to help TBI patients by increasing brain blood flow,
reducing inflammation and oxidative stress thereby relieving
neuropsychiatric symptoms and improving vitality.”
Exer-Rest is available in the United States, Canada and other
major international markets. It is an FDA listed medical device
intended as an aid to temporarily increase local circulation, to
provide temporary relief of minor aches and pains, to reduce
morning stiffness and to provide local muscle relaxation. The
Exer-Rest is also approved in the United Kingdom, European Union,
Health Canada and Mexico as an aid to increasing circulation and
for increasing joint mobility.
This press release contains "forward-looking statements," as
that term is defined under the Private Securities Litigation Reform
Act of 1995 (PSLRA). Many factors could cause our actual activities
or results to differ materially from the activities and results
anticipated in forward-looking statements. These factors include
those described in our filings with the Securities and Exchange
Commission, as well as risks and uncertainties associated with,
among other things, the uncertainty of the success, if any, of the
Research and Development Agreement between NIMS and the NMRC,
future financial results, additional financing requirements,
development of new products, government approval processes,
technological changes, obtaining regulatory approval in Japan,
establishing Japanese marketing, sales and distribution activities,
and other uncertainties. We intend that all forward-looking
statements be subject to the safe-harbor provisions of the
PSLRA.
Non Invasive Monitoring ... (PK) (USOTC:NIMU)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Non Invasive Monitoring ... (PK) (USOTC:NIMU)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
